Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study to evaluate the safety and how pivekimab sunirine works in children with relapsed or refractory acute myeloid leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Hungary Italy Spain
  • A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

    Recruiting

    3 1 1
    Czechia Denmark France Germany Hungary Italy +3
  • A study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer

    Recruiting

    3 1 1 1
    Belgium France Germany Greece Italy The Netherlands +2
  • A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Bulgaria France Germany Greece Hungary +8
  • Anti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Optimizing fludarabine phosphate exposure to improve event‑free survival in children and young adults with B‑cell acute lymphoblastic leukemia receiving CAR‑T therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany The Netherlands Spain
  • Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

    Recruiting

    3 1 1
    Cyprus Greece
  • One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Phase 3 Study of INCB123667 versus investigator’s choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

    Recruiting

    3 1 1 1
    Belgium France Germany Ireland Italy The Netherlands +2
  • A Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Poland +1